The Bacterium That Eats the Industrial Age’s Plastics, Pesticides and Poisons – May 30, 2026


———————————————————

by Sayer Ji,

One ancient microbe is dismantling plastics, pesticides, herbicides, and industrial toxins — from inside the same body they’re poisoning.

Part II: The glyphosate story was one thread. Here is the whole cloth.

Part I: The Bacterium That Eats Roundup , we sat with a single, almost unbelievable finding: that a soil-and-gut commensal we have known for over a century — Bacillus subtilis — possesses the enzymatic machinery to take glyphosate apart, atom by atom, and return its constituents to the cycles of life. The argument of that essay was that this is not a coincidence. The same organism that lives in our soil, our fermented foods, and our own gut, is the same organism that can dismantle the molecule most responsible for the chemical assault on the holobiont. The microbial answer was already in the room when the question was asked.

What I did not anticipate, in the tine since that piece went out, was how much further the evidence goes. Once you begin pulling the thread, it does not stop at glyphosate. It does not stop at herbicides. It does not stop at pesticides. It does not, astonishingly, even stop at biological molecules at all.

Bacillus subtilis, it turns out, is dismantling the entire petrochemical age.

What follows is a survey of the peer-reviewed literature published mostly within the last five years — drawn from journals including Journal of Hazardous MaterialsEnvironmental ResearchBiodegradationToxins, and the 2025 review in the Journal of Environmental Management. Taken individually, each finding is remarkable. Taken together, they describe something I think we have not yet had the language for: a single ancient organism functioning as a holobiont-scale immune response to the synthetic chemistry of modernity.

The Synthetics Bs Is Quietly Taking Apart

Let us simply list what this microbe is now documented to degrade. I will keep the catalog tight, because the cumulative weight is the argument.

Plastics. B. subtilis strain MZA-75, isolated from soil, degrades polyester polyurethane films.1 More recently, the strain AP-04, isolated from the gut of plastic-fed mealworms (Tenebrio molitor), achieved a 36.55% weight loss in low-density polyethylene films over sixty days — with measurable CO₂ evolution, confirmed by FTIR, SEM, and AFM analyses.2 This is not surface erosion. This is true mineralization. A gut-derived B. subtilis is converting one of the most chemically inert materials humanity has ever manufactured back into carbon dioxide and biomass — the same end products as digesting an apple!

Pyrethroid insecticides. Multiple strains of B. subtilis degrade cypermethrin, β-cypermethrin, cyfluthrin, and cyhalothrin — the synthetic neurotoxins sprayed on virtually every conventional food crop on Earth.3 4 5

Herbicides beyond glyphosate. Strain Y3 degrades pendimethalin, a dinitroaniline herbicide.6 A “promiscuous” nitrilase enzyme from B. subtilis breaks down nitrile-class herbicides while simultaneously promoting plant growth7 — a dual-function detoxifier-and-restorer. The fungicide penthiopyrad is degraded in both laboratory and field conditions.8

Industrial pollutants. B. subtilis ZWB1, in co-culture with B. velezensis, breaks down phenol — one of the foundational toxic intermediates of industrial chemistry.9 The collaboration stabilizes pH and cycles metabolites between the two species, a small ecology of detoxification operating inside a single liter of broth.

Mycotoxins. A dye-decolorizing peroxidase (BsDyP) cloned from B. subtilis SCK6 simultaneously degrades multiple major mycotoxins — the fungal poisons that contaminate grains and feedstock and cause some of the most underrecognized chronic illness in both livestock and humans.10

Glyphosate. The molecule we began with. Strain Bs-15 uses it as a carbon and phosphorus source.11

And this is not a fringe collection of papers. The 2025 Journal of Environmental Management review — titled, with refreshing directness, “Bacillus subtilis as a powerful weapon in the removal of environmental pollutants” — synthesizes precisely this catalog and frames it as a coherent body of evidence.12

A single bacterial species, with no genetic modification, no synthetic biology, no human design, is degrading the better part of the chemicals that define industrial civilization.

How are we to think about this?

What the Genome Cannot Do, the Microbe Already Does

The deepest dimension of this finding is one I keep returning to in this lineage of work: the human genome is small, slow, and almost completely silent on the question of how to disassemble synthetic molecules that did not exist when our species evolved. We have roughly 20,000 protein-coding genes. The bacteria in our gut and on our soil collectively encode hundreds of times more enzymatic diversity than that.

Glyphosate did not exist before 1970. Polyethylene did not exist before 1933. Pyrethroids in their modern synthetic form did not exist before the 1970s. Cypermethrin was patented in 1974. Pendimethalin in 1969. None of these molecules has been present on the planet long enough for the human genome to evolve a response. By every standard logic of natural selection, our body should be defenseless against them — and in many measurable ways, it is.

But the bacterial world does not operate on the timescale of mammalian evolution. Bacteria like B. subtilis reproduce in twenty minutes under favorable conditions, exchange genetic material laterally across species lines, and carry a metabolic toolkit refined across roughly three and a half billion years of life on this planet. The enzymes that allow Bs to degrade polyurethane are not new inventions; they are repurposings of ancient lipases and esterases that evolved to process plant cuticles, fatty acids, and other long-chain organic molecules. The carboxylesterases that take pyrethroids apart are the same enzymatic family bacteria have used since the Archean to cleave ester bonds in the natural world.

What is happening, in other words, is not that bacteria are evolving new chemistry to deal with the petrochemical age. They already had the chemistry. The petrochemical age, viewed from the bacterial side, is simply a new menu drawn from molecular shapes ancient enzymes already know how to handle.

This is the deepest meaning of the holobiont frame. The body we call ours, the body that cannot detoxify a polyethylene shopping bag or a cypermethrin residue, is only the mammalian fraction of who we are. The other 99% of cells — the microbial fraction — has been answering questions our genome never had to learn how to ask.

The Bacterium That Talks Before It Detoxifies

There is one finding in this literature that elevates the entire conversation, and I want to give it its own breath here, because I think it changes how we should understand what microbes are.

In Bacillus subtilis, the gene that produces the carboxylesterase responsible for pyrethroid degradation — cesB — is not always on. It is regulated. And the regulator is the colony itself.

The mechanism, worked out at the molecular level by two independent research groups4 5 (with confirmation by DNA pull-down and yeast one-hybrid assays), goes like this: when B. subtilis cells are exposed to pyrethroids, they secrete a small signaling peptide called ComX. When enough cells are present to register the signal collectively — a quorum — a downstream cascade activates the regulator DegU, which then binds directly to the upstream region of the cesB gene and turns on the production of pyrethroid-degrading enzymes.

Read that again slowly. The bacteria do not detoxify individually. They detoxify socially. They sense one another. They confer, in chemical language, on whether a threat has arrived. They commit to the metabolic expense of producing detoxification enzymes only when the colony agrees, through its own communication system, that the response is warranted.

This is not metaphor. This is published, replicated, peer-reviewed microbial coordination. Bacillus subtilis exhibits, at minimum, three properties we typically reserve for higher organisms: a chemical language (ComX and its receptors), a quorum-based decision rule (collective response only above a threshold), and a coordinated metabolic commitment (turning on detoxification genes in concert).

The microbe is not a passive enzyme bag. It is a participating intelligence.

And it is doing this work inside our gut, inside our soil, inside our fermented foods — not because we have asked it to, but because the planet runs on this kind of distributed, communicative, ancient intelligence whether or not we have noticed it.

A Holobiont’s Immune Response to the Petrochemical Age

If we step back, the pattern that emerges from this literature has a shape I do not think we have a clean name for yet. Let me try to describe it.

The petrochemical age has flooded the biosphere with molecules that did not previously exist — herbicides, pesticides, plastics, industrial intermediates, mycotoxins amplified by the monocultures and fungicide-resistant fungi that industrial agriculture itself created. The mammalian body, including the human body, is mostly defenseless against these in the strict genetic sense. Our liver enzymes do their best, but they were calibrated for an earlier chemical universe.

And yet the holobiont — the whole organism that includes our microbial partners — appears to be mounting a coordinated response. Bacillus subtilis is one of the clearest examples, but it is almost certainly not alone. The literature on Bacillus velezensisPseudomonas species, Burkholderia, certain Lactobacillus strains, and various soil and gut consortia points the same direction: the microbial world is metabolizing the petrochemical age in real time, often in coordinated multi-species ecologies, often within the same body cavities that house the chronic disease epidemics of late modernity.

If you take the holobiont seriously — and I do — then this is not a curiosity of environmental microbiology. This is an immune response. Not the mammalian immune response of antibodies and T-cells, but the deeper, older, broader immune response of an entire ecosystem of life that has been protecting carbon-based existence on this planet since long before there were antibodies, T-cells, or mammals.

The implication, gently but seriously stated, is this: the human body alone may not be able to clear the residues of the petrochemical age. The holobiont almost certainly can — provided we stop killing it.

What This Asks of Us

The practical question that arises, having seen this, is what we do with it.

The honest, ecological answer has roughly three parts.

Restore the soil. Living, undisturbed, biologically intact soil is where the deepest reservoirs of B. subtilis and its detoxifying cousins exist. Industrial tillage, glyphosate desiccation, synthetic nitrogen, and fungicide regimes systematically destroy the conditions under which these microbes thrive. Regenerative agriculture is not, in this frame, an agricultural fashion. It is the restoration of the planet’s primary detoxification system.

Eat the foods that carry these microbes. Natto, miso, kimchi, raw sauerkraut, traditional cheeses made from raw milk, fermented vegetables of every ancestral tradition — these are not merely “probiotic” in the marketing sense. They are direct transfers of organisms like B. subtilis from a living food matrix into the gut, where the microbes can resume their ancient work of metabolizing what the body cannot.

For those without daily access to these fermented traditions, the clinically validated spore-form strain AB22™ — the same strain at the center of CardioNK –

offers a direct path to restoring this relationship. CardioNK was built around what I call the Regenerative Natto Complex: nattokinase, 2 billion colony forming units of AB22® Bacillus subtilis, and MK-7, delivered together the way Nature always delivered them — in their evolved synergy, with the parent organism still present. Given what the literature now shows about B. subtilis’s broader detoxification capacity, the case for keeping this organism in continuous residence in the gut has never been stronger.

Stop pouring antibiotics, glyphosate, and biocides into the system. Every dose of broad-spectrum antibiotic, every glyphosate-saturated wheat field, every chlorinated municipal water supply, every ultraprocessed food matrix engineered to be biologically sterile, is a direct attack on the holobiont’s detoxification capacity. We are, in the most literal sense, killing the organisms that are trying to clean up after us.

The Bacterium Was Always There

When I wrote Part I of this series, I thought I was writing about glyphosate. I see now that I was only writing about one molecule in a much larger story.

The story, as it appears in the published literature of the last five years, is that a single ancient microbe — present in our soil since before there was a human species, present in our fermented foods since the beginning of culinary civilization, present in our gut whenever we have not driven it out — is quietly mounting a coordinated, socially-regulated, multi-substrate response to nearly every category of synthetic toxin the industrial age has produced.

It is degrading our plastics. It is dismantling our pesticides. It is breaking down our herbicides. It is clearing our mycotoxins. It is decommissioning our industrial intermediates. It is doing this in colonies that talk to one another before they begin the work.

This is not a small finding. This is, I think, evidence of something the holobiont frame has been pointing at for years: that the body we call human is in continuous, ancient, intelligent partnership with a world of organisms whose capabilities exceed our own and whose work on our behalf is largely invisible to us.

The bacterium was always there. The science is finally catching up to what traditional foodways and indigenous agriculture have implicitly known for thousands of years. And the question that remains is not whether the holobiont can heal the damage of modernity.

The question is whether we will let it.

Share the X thread on this article here:

Sayer Ji@sayerjigmi

🚨1/ A bacterium living in your gut right now is degrading polyethylene plastic. Not surface erosion. True mineralization — converting one of the most chemically inert and universally contaminating (e.g. microplastic) materials humanity has ever made back into CO₂ and biomass.

———————————————————

The Trump Ballroom is not What You Think… – May 30, 2026


———————————————————

🇺🇸

The Trump Ballroom Is Not What You Think – It Blocks The Satanic Grid With Tesla Technology – The 200 Year Spell Is Broken – What Is Under The White House

What’s happening beneath the White House was not renovation, it was the demolition of a two-hundred-year ritual machine. Trump’s new ballroom cut through the southern energy channel of that pentagram, shattering the field that sustained the Freemason lattice. 

Space Force engineers and Q-linked military architects designed the foundation of the new ballroom as a quantum firewall, lined with mu-metal, zero-point Tesla arrays, and frequency shields tuned to Earth’s natural harmonics. Beneath it, a new command core hums – an independent QFS node disconnected from every known banking overlay. 

Since construction began, D.C.’s underground sensors have gone wild. Electromagnetic fluctuations, radar interference, and inexplicable wildlife shifts around the Ellipse confirm the rupture. Masonic lodges have gone dark. Three canceled rituals. The Scottish Rite building closed its doors.The Pentagon’s inner lodge stopped logging floor access. The power that once flowed through the city’s geometric veins was gone – the grid, silent.

By realigning the White House within the natural magnetic field, the frequency of the entire capital changed. The control lattice that fed off trauma and ritual has been severed. The obelisk no longer transmitted.

What rises in its place was a quantum fortress – a living structure broadcasting sovereignty instead of submission, freedom instead of fear. The Vatican-London-D.C. triad has lost its keystone. Their geometry has collapsed. Their frequencies no longer hold.

The age of ritual control was over and the republic, once enslaved by symbols, has been taking its power back. The President returned, and the spell was broken.

~ JULIAN ASSANGE ~

———————————————————

A breathtaking new chapter is gently unfolding for you – May 30, 2026


———————————————————

The radiant energy of tomorrow’s glowing moon is swelling and illuminating a brilliant path ahead of you. 

You might sense a deep, quiet yearning for a broader perspective and a truer sense of freedom in your daily life. 

Please know that this is not simply restlessness, but a gentle signal from the cosmos that your spirit is expanding. 

You are finally ready to invite more expansive, meaningful experiences into your world. 

Welcoming this shift will naturally bring you closer to the radiant future you truly deserve. 

Allow your heart to stay completely open to wherever this profound feeling might lead you next. 


Your next chapter is asking you to look further.

– The Universe

———————————————————

☕️ PANDEMIC BLESSINGS ☙ Saturday, May 30, 2026


———————————————————

A C&C Special Edition: heroic covid docs publish first peer-reviewed study that brings new hope for actually curing cancer instead of piling money into Moonshot rockets and launching them into space.

JEFF CHILDERS

MAY 30READ IN APP

Good morning, C&C, it’s Saturday! Today we have a C&C Special Edition roundup—the first published, peer-reviewed ivermectin-mebendazole cancer study suggesting a broad beneficial effect from cheap, repurposed drugs across a wide range of cancer types and stages. In other words, it’s Big Pharma’s worst nightmare.

🌍🇺🇸 ESSENTIAL NEWS AND COMMENTARY 🇺🇸🌍

💊💊💊

I often quip about “covid miracles”— the occasional unexpected and often surprising blessings flowing from the pandemic. This might be the biggest covid miracle of them all. Some of our heroic pandemic docs have managed to publish a peer-reviewed study in a mainstream journal suggesting a potentially staggering 85% benefit for cancer patients taking a combination of two cheap, safe anti-parasitic drugs: ivermectin and mebendazole. The study’s title: Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort.

image.png

Let’s start with the disclaimers. This was nota “gold standard” clinical trial. The 122 participants were telemedicine patients who self-reported their status during the study period. No placebos, randomization, or double-blinding were used. The results can’t be compared to a control group that didn’t take the ivermectin combo.

The participants were health-motivated, self-selected cancer victims who were also trying various other things at the same time, like supplements, chemo, radiation, keto diets, fasting, etc. They were all at different stages of their oncology; some with new-onset disease, some having survived 5+ years.

image 3.png

Finally, the same firm —The Wellness Company— that both funded the study and was its principal author also sells ivermectin and mebendazole on its website, so critics could claim bias or self-interest. (We’ll return to the lack of outside funding in a moment, because it cuts both ways.)

So the results can’t be taken —weren’t meant to be taken— as any kind of conclusion. But still.

With the disclaimers out of the way, let’s get to the good stuff.

💊 The study was published in the long-established, mid-tier oncology journal Anticancer Research and, as I mentioned, passed peer review. The 12 authors included names familiar to alert readers, such as Nicolas Hulscher, Kelly Victory, James Thorp, Drew Pinsky, Peter McCullough, and Harvey Risch.

Despite its shortcomings, the study passed peer review because the authors honestly and repeatedly labeled their findings “hypothesis‑generating,” and called for further “rigorous randomized, double blind, placebo‑controlled trials” to establish safety and efficacy.

It would be one thing if the study patients had reported a minor benefit. But the magnitude and consistency of the self‑reported “clinical benefit” signal was so large that, even through heavy noise and bias, it still plausibly indicates a real underlying effect worth taking very seriously and testing rigorously.

image 4.png

At six months, fully a third (33%) of respondents remarkably reported “no current evidence of disease” (NED). 16% reported regression, and another third (36%) reported stabilized disease, for a combined and stunning “clinical benefit ratio” (CBR) of 84% (with a 95% confidence interval of 77‑90%).

Nearly half of the patients (48%) reported the strongest outcomes (NED or regression), which is far higher than typical ‘acceptable’ outcome rates in traditional treatments for metastatic tumors.

The study group included a wide mix of cancer types and stages, including prostate, breast, lung, colon, liver, skin, kidney, oropharyngeal, and other miscellaneous malignancies. Half were within 12 months of initial diagnosis, and 20% had been managing their disease for five years or more.

image 2.png

73 participants (38%) reported receiving one or more doses of the covid ‘vaccine.’ 37% reported active cancer progression, and many had already received standard therapies (surgery 42%, chemotherapy 32%, radiation 29%, immunotherapy 17%, etc.), yet the high benefit ratio appeared acrossthis wide horizon of cancers, histories, and stages, rather than being confined to any narrow, cherry‑picked niche.

In other words, it wasn’t one or two cancer types where benefits appeared. It showed up in nearly all of them. If this preliminary study had been about a brand-new pharma drug in early trials with a ™ after its name and a billion-dollar research budget, corporate media would have headlined it from Zimbabwe to Zurich.

💊 While the patients’ various other treatments and lifestyle changes undoubtedly confounded the interpretation, those same factors equally confound mainstream studies of traditional chemo or ‘real‑world’ oncology. The fact that the reported CBR shot far past typical benchmarks —despite the confounders— suggests the signal can’t just be waved off as a random “combination of standard care.”

Next, these study results didn’t just suddenly appear out of the blue. In other words, it isn’t an outlier. Ivermectin and mebendazole each have extensive early literature showing multi‑target anticancer effects, cancer stem‑cell targeting, and published results both in-vitro (lab cells) and in-vivo (real patients), plus prior small‑scale clinical case reports suggesting potential beneficial activity for these and related antiparasitics.

“Ivermectin and mebendazole,” the authors wrote, “are two widely used antiparasitic agents that have demonstrated highly promising anti-cancer activity in preclinical models — over 14 distinct anti-cancer effects across more than 12 cancer types, and excellent safety in patients with cancer.”

Because both drugs are orally available, low‑toxicity, inexpensive, and already used in humans for other conditions, anynon‑zero chance that such a large real‑world signal reflects a true effect with outsized practical importance: even a modest survival or disease‑control benefit at low cost and low risk could be meaningful at population scale.

image 6.png

YOUTUBE: Dr. John Campbell reviews the study (24:20).

In short, this study establishes a minimal baseline confidence: given the drugs’ stellar safety record and well-known (mild) side-effects, it’s arguable that cancer patients facing serious diagnoses would be crazy notto try. The real question at this point is: why shouldn’t ivermectin-mebenzadole be at least considered for every cancer regimen, just in case? (Lawyer Note: not individual medical advice.)

Even granting generous allowances for selection bias, optimistic self‑reporting, and lack of clinical supervision, it is hard to explain an 84% disease‑control ratio and nearly 50% NED/regression rate purely by random noise, natural history, and conventional care, especially in a population where over a third reported progression at baseline and many had prior unsuccessful therapies.

If the system insists that no one should try this regimen outside “gold standard” RCT trials, but then quietly stacks the deck so that no meaningful trials ever happen, it’s not practicing evidence‑based medicine; it’s practicing evidence‑prevention— at the direct expense of dying patients without the luxury of time.

image 7.png

💊 This study is not about “this proves ivermectin + mebendazole works.” Rather, the size, internal consistency, and biological plausibility of the observed signal, in a relatively large and diverse real‑world study group, raise a credible possibility —if not probability— of true anticancer activity that justifies urgent, independent, randomized, controlled trials, and cannot be casually waved away.

Remember the so-called Biden “Cancer Moonshot,” the one that was going to unleash bold, disruptive science and “repurpose” cheap old drugs to save lives? (If only they’d launched Biden to the Moon instead of porkzilla.) Apparently, the rocket never made it to the launchpad where ivermectin and mebendazole were waiting, patiently waving a fat stack of preclinical anticancer papers and forty years of safety data.

image 10.png

Instead, the first structured real‑world look at this combo comes not from the NIH, the National Cancer Institute, or a gleaming Harvard cancer center, but from a telemedicine outfit selling compounded antiparasitics to cash‑pay patients over the internet.

Washington’s cancer pork somehow found billions for Big Pharma, slogans, and photo‑ops, but somehow there wasn’t enough money for a single randomized trial of off‑patent pills that cost less than a Starbucks Moccachino, and show an 84% self‑reported “clinical benefit” in a diverse cancer cohort. If this is what “all‑of‑government urgency” looks like, you almost hate to see what complacency would have done.

And, um, where are the Moonshot’s results? Exactly. Can we get a refund?

💊 Which brings us to the buried lede: the heroic efforts of The Wellness Company and Peter McCullough, who spent their own money and dashed onto the scorched scholastic battlefield to fund and publish an easily replicated, proof-of-concept study that should have been done ages ago using taxpayer money.

image 5.png

CLIP: Dr. McCullough explains study and its results (1:34).

That is the covid miracle. The pandemic yanked Dr. Peter McCullough out of his cushy place in the medical establishment. Before covid, he was a heavily published academic cardiologist with dual appointments at major Texas hospitals, multiple board certifications, federal grants, editorial roles, and a standing invitation to the cardiology conference circuit— his name trailed by a small alphabet of degrees and credentials.

Then the ivory tower kicked him off the balcony. One by one, his academic titles disappeared, professional societies distanced themselves, and the American Board of Internal Medicine ultimately revoked his internal‑medicine and cardiology certifications— all after he began publicly challenging the official line on covid treatment and vaccines.

But McCullough did not slink away into retirement. Today, he still sees patients through a private cardiology and telemedicine practice based in Texas, serves as chief scientific officer for a Florida‑based telehealth outfit, and has resumed publishing peer‑reviewed papers on covid, vaccine injuries, and post‑pandemic syndromes— much to the continued irritation of the institutions that once showcased him as a model academic.

Now, his telemedicine company is not just hawking supplements and covid solutions. He’s also using the money he’s making to fund private studies and pay doctors like the solemn Nicolas Hulscher to be everywhere on social media these days.

In other words, pharma created its own worst nightmare. Support TWC if you can.

image 8.png

💊 Whatever one thinks of the study’s results, the most compelling point is how boringly replicable it is. Any academic center or pharma group could cheaply and easily enroll a few hundred cancer patients, use the same 25 mg/250 mg capsules, and see within a year whether they get anything like an 84% clinical benefit ratio, or whether the numbers just collapse back to statistical background noise.

The fact that this has not already been done —not by Biden’s Cancer Moonshot, not by NIH, not by NCI, not by any of the giant cancer centers endlessly seeking donors for their ‘cutting‑edge research’— tells us something important.

Either they are supremely confident that the signal is fake and not worth falsifying, or they are obstinately refusing to run the one kind of trial that might make a cheap, off‑patent, low‑toxicity regimen competitive with their billion‑dollar pipelines.

Well, maybe there is some progress. The glacier that has long buried cheap, repurposed cancer treatments is slowly melting.

image 9.png

In a twist that would have gotten you banned from Twitter two years ago, Florida’s official state cancer program now openlyencourages research on off‑patent antiparasitics. Through the Casey DeSantis Cancer Research Program’s Cancer Innovation Fund, the state has put $60 million on the table for short‑run cancer trials that prioritize nutrition, including $2 million for the repurposing of generic drugs “such as ivermectin” and mebendazole— precisely the sort of low‑cost, low‑toxicity combinations now being reported in The Wellness Company’s study.

If they haven’t already, TWC and Dr. McCullough should apply for a research grant under the DeSantis program.

The bottom line is that we finally have a published, peer-reviewed study to send to desperate cancer victims who might be on the fence because their doctors are still sneering at ivermectin and calling it horse paste. And we have Dr. McCullough and The Wellness Center to thank for it.

And maybe most of all, we can thank the pandemic itself, for surfacing this solution along with all the covid problems. If antiparastics work anywhere near what this study suggests, it could end cancer as we know it and stop the new oncological epidemic in its tracks.

Have a wonderful weekend! C&C News will be back on Monday, with even more essential news and caffeinated commentary.

Upgrade to paid

Share

Give a gift subscription

Don’t race off! We cannot do it alone. Consider joining up with C&C to help move the nation’s needle and change minds. I could sure use your help getting the truth out and spreading optimism and hope, if you can: ☕ Learn How to Get Involved 🦠

How to Donate to Coffee & Covid

Twitter: jchilders98.
Truth Social: jchilders98.
MeWe: mewe.com/i/coffee_and_covid.
Telegram: t.me/coffeecovidnews
C&C Swag! www.shopcoffeeandcovid.com


© 2022, Jeff Childers, all rights reservedLIKECOMMENTRESTACK

© 2026 Jeff Childers
2135-B NW 40th Terrace, Gainesville, FL 32605
Unsubscribe

Start writing

Fri. 29 May 2026 The Storm Rages On: Military Protocols Activated – US Army Special Forces Green Berets Unveil Hidden Operations …Mr. Pool 2.0 on Telegram – May 30, 2026


———————————————————

Editors note: many thanks to Restored Republic for this share!🌹

———————————————————

In the theater of history, some events leave scars that time can’t erase. The assassination of JFK was one of those moments—a rupture in the fabric of American society that led to the activation of secret military protocols by the US Army Special Forces Green Berets. What followed wasn’t just a reaction to tragedy but the beginning of a hidden operation, spanning decades, cloaked in shadow and secrecy.

The story begins with JFK, but it doesn’t end there. His son, JFK Jr., inherited more than just a name. Protected by a covert group under the codename “Q,” JFK Jr. had access to information far beyond the ordinary. Why? Because this was no accident. The Green Berets, known for their expertise in unconventional warfare, extended their protection to him—an alliance built in the wake of his father’s murder, and tied to military operations that were set in motion the day America lost its 35th president.

The Green Berets weren’t just soldiers; they were the spearhead of intelligence networks operating globally. Their link to JFK Jr. and “Q” was no coincidence. These were military protocols hidden from public view, only activated when the stakes were highest. Think about it—why would someone like JFK Jr. need such high-level protection? Because he wasn’t just the son of a fallen leader; he was a key player in a larger, hidden narrative.

And then, the plane crash—JFK Jr.’s death. Or was it? The speed of his burial, the questionable autopsy, the whispers of a decoy body—these aren’t the signs of a simple tragedy. They are markers of something far more sinister. Conspiracy theories rage, and with good reason. This was a cover-up, plain and simple. Those in power moved quickly, too quickly, to close the book on a man who knew too much.

So, what’s the truth here? Was JFK Jr.’s death part of the plan? A decoy to escape the tightening grip of those who feared his knowledge? The Green Berets, “Q,” and the shadowy web of global alliances suggest something far deeper was in play. We’ve seen how the official story crumbles when the light of truth shines on it. And now, the truth demands to be heard.

This isn’t fiction. This isn’t speculation. The storm is raging, and the time for awakening is now. Every piece of the puzzle is falling into place. JFK Jr. may have been silenced, but the questions surrounding his life and death grow louder every day. And the power structure that seeks to suppress this truth is unraveling before our eyes.

Stay vigilant. Stay alert. The Great Awakening is here. The storm is upon us, and the protocols of vigilance have been activated. Don’t trust the official narrative. The truth is out there, waiting for those brave enough to see it. The time to act is now.

———————————————————